Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.95USD
15 Dec 2017
Change (% chg)

$0.02 (+0.34%)
Prev Close
$5.93
Open
$5.93
Day's High
$6.07
Day's Low
$5.90
Volume
243,934
Avg. Vol
85,805
52-wk High
$6.65
52-wk Low
$1.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.93 -0.159
Jun '17 1.85 -0.232
Mar '17 1.34 -0.186
FY 2016 Dec '16 2.73 -0.152
Sep '16 0.79 -0.144
Jun '16 1.07 -0.144
Mar '16 1.25 -0.104
FY 2015 Dec '15 2.14 -0.073
Sep '15 0.41 -0.101
Jun '15 0.16 -0.120
Mar '15 0.22 -0.126
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 3.79 4.20 3.18 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 3 10.91 11.32 10.30 5.73
Year Ending Dec-18 3 12.56 15.00 10.50 2.10
Earnings (per share)
Quarter Ending Dec-17 3 -0.13 -0.12 -0.15 --
Quarter Ending Mar-18 1 -0.14 -0.14 -0.14 --
Year Ending Dec-17 3 -0.71 -0.70 -0.73 -0.61
Year Ending Dec-18 3 -0.64 -0.51 -0.74 -0.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 27.06 122.78 5.95
Price to Book (MRQ) 58.36 23.45 5.68
Price to Tangible Book (MRQ) 58.47 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 50.65 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 400.27 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 87.83 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -10.53 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -56.77 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 2.44 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -104.86 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -274.45 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -279.06 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -310.42 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -321.80 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 201,011 22,314,532 851,801,741
Net Income/Employee (TTM) -646,859 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.14 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.46 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -67.74 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -175.89 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 98.87 -22.30 --
EPS (TTM) % -33.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pieris Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.66%
# of Holders: 93
Total Shares Held: 22,690,872
3 Mo. Net Change: 246,143
# New Positions: 26
# Closed Positions: 3
# Increased Positions: 52
# Reduced Positions: 20
# Net Buyers: 32
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.